A case of afterload mismatch associated with shivering leading to fetal hypoxia in a COVID-19 patient
© 2022. The Author(s)..
BACKGROUND: Fever and associated shivering are frequent symptoms in patients with coronavirus disease 2019 (COVID-19). High body temperature activates the immune system, which might be beneficial. However, shivering leads to high oxygen demand.
CASE PRESENTATION: A 38-year-old man diagnosed with COVID-19 was transferred to our intensive care unit (ICU). His oxygen saturation (SpO2) level was approximately 92-95% and was managed with a high flow nasal cannula. Six hours after admission to the ICU, he started shivering, and his systolic blood pressure rose above 200 mmHg. Concomitantly, his SpO2 levels decreased rapidly. Mechanical ventilation was started, but oxygenation could not be maintained, requiring the establishment of extracorporeal membrane oxygenation (ECMO).
CONCLUSIONS: COVID-19 is known to cause thrombosis in the pulmonary microvasculature at the early stage of the disease. Under these circumstances, caution should be paid since shivering may worsen the patient's condition.
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
JA clinical reports - 8(2022), 1 vom: 16. Juli, Seite 51 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Suzuka, Takanori [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 03.08.2022 published: Electronic ErratumIn: JA Clin Rep. 2022 Aug 4;8(1):57. - PMID 35922725 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1186/s40981-022-00542-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM34361104X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM34361104X | ||
| 003 | DE-627 | ||
| 005 | 20231226020842.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s40981-022-00542-3 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1145.xml |
| 035 | |a (DE-627)NLM34361104X | ||
| 035 | |a (NLM)35840861 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Suzuka, Takanori |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A case of afterload mismatch associated with shivering leading to fetal hypoxia in a COVID-19 patient |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 03.08.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a ErratumIn: JA Clin Rep. 2022 Aug 4;8(1):57. - PMID 35922725 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2022. The Author(s). | ||
| 520 | |a BACKGROUND: Fever and associated shivering are frequent symptoms in patients with coronavirus disease 2019 (COVID-19). High body temperature activates the immune system, which might be beneficial. However, shivering leads to high oxygen demand | ||
| 520 | |a CASE PRESENTATION: A 38-year-old man diagnosed with COVID-19 was transferred to our intensive care unit (ICU). His oxygen saturation (SpO2) level was approximately 92-95% and was managed with a high flow nasal cannula. Six hours after admission to the ICU, he started shivering, and his systolic blood pressure rose above 200 mmHg. Concomitantly, his SpO2 levels decreased rapidly. Mechanical ventilation was started, but oxygenation could not be maintained, requiring the establishment of extracorporeal membrane oxygenation (ECMO) | ||
| 520 | |a CONCLUSIONS: COVID-19 is known to cause thrombosis in the pulmonary microvasculature at the early stage of the disease. Under these circumstances, caution should be paid since shivering may worsen the patient's condition | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Afterload mismatch | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Shivering | |
| 700 | 1 | |a Naito, Yusuke |e verfasserin |4 aut | |
| 700 | 1 | |a Uemura, Keiko |e verfasserin |4 aut | |
| 700 | 1 | |a Ida, Mitsuru |e verfasserin |4 aut | |
| 700 | 1 | |a Egawa, Junji |e verfasserin |4 aut | |
| 700 | 1 | |a Kawaguchi, Masahiko |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t JA clinical reports |d 2015 |g 8(2022), 1 vom: 16. Juli, Seite 51 |w (DE-627)NLM28115581X |x 2363-9024 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2022 |g number:1 |g day:16 |g month:07 |g pages:51 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s40981-022-00542-3 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2022 |e 1 |b 16 |c 07 |h 51 | ||